REGN668
R668-AD-0914
Phase 1 mab completed
Quick answer
REGN668 for Dermatitis is a Phase 1 program (mab) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Regeneron UK Limited
- Indication
- Dermatitis
- Phase
- Phase 1
- Modality
- mab
- Status
- completed